Updates in pediatric nutrition.
Ongoing research in several areas of pediatric nutrition has new practical applications for community-based pediatricians. For example, a fresh understanding of risk factors for rickets persuades pediatricians to recognize and treat this disease, which was thought to be nearly extinct in the modern industrialized world. Similarly, an expanded awareness of the antibacterial components of breast milk encourages a more complete dialogue between pediatricians and new mothers about the potential benefits of breast-feeding. For those infants with feeding intolerance, new data help to refine the indications for hypoallergenic formulas, which are increasingly recommended for children with a variety of symptoms. The past year also has seen breakthroughs in our understanding of supplemental nutrition for children. Vitamin A may provide direct benefits for the most vulnerable of children, namely premature infants at high risk for lung disease. At the other end of the pediatric spectrum, adolescent athletes seeking to enhance their performance are consuming poorly studied sports supplements that may not be beneficial and may even be toxic. Finally, a greater appreciation for the epidemic of obesity that is sweeping the United States and other countries suggests that children at high risk may represent a far more diverse population than had been recognized previously.
Oken
E
E
Women's Health Center, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. eoken@partners.org
Lightdale
J R
JR
D000293:Adolescent; D001942:Breast Feeding; D002648:Child; D002664:Child Nutritional Physiological Phenomena; D002675:Child, Preschool; D003401:Creatine; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D007223:Infant; D007225:Infant Food; D007231:Infant, Newborn; D007234:Infant, Premature; D009765:Obesity / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D011247:Pregnancy; D012279:Rickets / Q000175:diagnosis / Q000503:physiopathology / Q000517:prevention & control; D014481:United States; D014801:Vitamin A / Q000627:therapeutic use
D014801:Vitamin A; D003401:Creatine